Renal Cell Carcinoma (Kidney Cancer) Support Group
Renal cell carcinoma, also known by a gurnistical tumor, is the most common form of kidney cancer arising from the renal tubule. It is the most common type of kidney cancer in adults. Initial therapy is with surgery. It is notoriously resistant to radiation therapy and chemotherapy, although some cases respond to immunotherapy.
CyberKnife Benefits Patients with Difficult Tumors
Patients with tumors along the spinal cord or in other critical locations can now benefit from state-of-the-art treatment that directs high-dose radiation at the tumor while preserving healthy tissues.
A noninvasive procedure, it is the latest development in stereotactic radiosurgery technology and goes by the name CyberKnife. UCSF Medical Center is one of only 12 health care institutions in the country offering this treatment to patients.
--------------------------------------------------------------------------------
Print story
E-mail story
--------------------------------------------------------------------------------
With the addition of CyberKnife, UCSF physicians have every weapon in the modern arsenal to fight tumors in hard-to-treat areas, according to William Wara, MD, professor and chair of the UCSF Department of Radiation Oncology.
He said the precision targeting of this device offers a significant improvement for some patients with tumors of the lung, pancreas, head or neck, as well as those with spine and brain tumors, both benign and malignant.
Patients with tumors along the spinal cord or in other critical locations can now benefit from state-of-the-art treatment that directs high-dose radiation at the tumor while preserving healthy tissues.
A noninvasive procedure, it is the latest development in stereotactic radiosurgery technology and goes by the name CyberKnife. UCSF Medical Center is one of only 12 health care institutions in the country offering this treatment to patients.
--------------------------------------------------------------------------------
Print story
E-mail story
--------------------------------------------------------------------------------
With the addition of CyberKnife, UCSF physicians have every weapon in the modern arsenal to fight tumors in hard-to-treat areas, according to William Wara, MD, professor and chair of the UCSF Department of Radiation Oncology.
He said the precision targeting of this device offers a significant improvement for some patients with tumors of the lung, pancreas, head or neck, as well as those with spine and brain tumors, both benign and malignant.
Yes..gamma knife and cyberknife have been studied for brain metastasis from renal cell carcinoma and more centers are able to provide this therapy.
1) Gamma Knife surgery is effective for metastatic brain tumors from renal cell carcinoma. While the DISAPPEARANCE rate of tumors is relatively low the GROWTH control is high.
2) Gamma Knife surgery should be used as the initial treatment in patients with multiple metastases from renal cell carcinoma.
3) Repeated gamma knife is recommended for newly developed brain metastases because of the low sensitivity of renal cell carcinoma to conventional radiation
Dr O.